CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Chongqing Lummy Pharmaceutical Co Ltd Company Snapshot
Chongqing Lummy Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Lummy Pharmaceutical Co Ltd with three other companies in this sector in China: Zhejiang Shapuaisi Pharmaceutical Co Ltd (2015 sales of 921.67 million Chinese Renmimbi [US$134.77 million] of which 100% was Medicine), Henan Taloph Pharmaceutical Stock Company Limited (1.02 billion Chinese Renmimbi [US$148.74 million] of which 59% was Medicine Distribute), and Betta Pharmaceuticals Co Ltd (914.60 million Chinese Renmimbi [US$133.73 million] ).

Sales Analysis. During the year ended December of 2015, sales at Chongqing Lummy Pharmaceutical Co Ltd were 963.85 million Chinese Renmimbi (US$140.93 million). This is an increase of 5.7% versus 2014, when the company's sales were 911.69 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Chongqing Lummy Pharmaceutical Co Ltd (and since 2010, sales have increased a total of 155%). Sales of Other Operations saw an increase that was more than double the company's growth rate: sales were up 389.3% in 2015, from 1.77 million Chinese Renmimbi to 8.65 million Chinese Renmimbi. Chongqing Lummy Pharmaceutical Co Ltd also saw significant increases in sales in Chemical Manufacturing (up 8.1% to 901.47 million Chinese Renmimbi) . Not all segments of Chongqing Lummy Pharmaceutical Co Ltd experienced an increase in sales in 2015: sales of Chemical Distribution fell 29.5% to 53.85 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Chongqing Lummy Pharmaceutical Co Ltd
  Stock Performance Chart for Chongqing Lummy Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 8.54
(Figures in Chinese Renmimbi)
1 Week -0.9%   13 Weeks 0.6%  
4 Weeks -2.2%   52 Weeks -6.3%  
 
Chongqing Lummy Pharmaceutical Co Ltd Key Data:
  Ticker: 300006 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 963,845,002
(Year Ending Jan 2016).
Employees: 1,625
  Currency: Chinese Renmimbi Market Cap: 6,936,539,891
  Fiscal Yr Ends: December Shares Outstanding: 812,241,205
  Share Type: Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.